1. Repository of OAI
Ελληνικά   English  

Browsing by Author Bairaktari, E.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 7 to 26 of 127 < previous   next >
TitleAuthor(s)Issue date???itemlist.???
Antigenic role of single residues within the main immunogenic region of the nicotinic acetylcholine receptorPapadouli, I.; Potamianos, S.; Hadjidakis, I.; Bairaktari, E.; Tsikaris, V.; Sakarellos, C.; Cung, M. T.; Marraud, M.; Tzartos, S. J.24-Nov-2015-
Antigenic Role of Single Residues within the Main Immunogenic Region of the Nicotinic Acetylcholine-ReceptorPapadouli, I.; Potamianos, S.; Hadjidakis, I.; Bairaktari, E.; Tsikaris, V.; Sakarellos, C.; Cung, M. T.; Marraud, M.; Tzartos, S. J.24-Nov-2015-
Apolipoprotein E polymorphism in northwestern Greece: frequency and effect on lipid parametersLiberopoulos, E.; Miltiadous, G.; Hatzivassiliou, M.; Ayrton, N.; Bairaktari, E.; Cariolou, M.; Elisaf, M. S.24-Nov-2015-
Apolipoprotein(a) phenotypes and lipoprotein(a) concentrations in patients with renal failureMilionis, H. J.; Elisaf, M. S.; Tselepis, A.; Bairaktari, E.; Karabina, S. A.; Siamopoulos, K. C.24-Nov-2015-
Apolipoproteins C-Ii and C-Iii and Small Dense Ldl Cholesterol Levels in Non-Diabetic Obese Subjects with Metabolic SyndromeFilippatos, T.; Tsimihodimos, V.; Kostapanos, M.; Kostara, C.; Tzallas, C.; Bairaktari, E.; Tselepis, A.; Elisaf, M.24-Nov-2015-
Are the effects of tamoxifen on the serum lipid profile modified by apolipoprotein E phenotypes?Liberopoulos, E.; Karabina, S. A.; Tselepis, A.; Bairaktari, E.; Nicolaides, C.; Pavlidis, N.; Elisaf, M.24-Nov-2015-
Association of serum and follicular fluid SHBG levels and SHBG (TAAAA)n polymorphism with follicle size in women undergoing ovarian stimulationHatzi, E.; Bouba, I.; Galidi, A.; Lazaros, L.; Xita, N.; Sakaloglou, P.; Kolios, G.; Bairaktari, E.; Kaponis, A.; Zikopoulos, K.; Tsatsoulis, A.; Georgiou, I.24-Nov-2015-
Atorvastatin preferentially reduces LDL-associated platelet-activating factor acetylhydrolase activity in dyslipidemias of type IIA and type IIBTsimihodimos, V.; Karabina, S. A. P.; Tambaki, A. P.; Bairaktari, E.; Goudevenos, J. A.; Chapman, M. J.; Elisaf, M.; Tselepis, A. D.24-Nov-2015-
Atorvastatin preferentially reduces LDL-associated platelet-activating factor acetylhydrolase activity in dyslipidemias of type IIA and type IIBTsimihodimos, V.; Karabina, S. A.; Tambaki, A. P.; Bairaktari, E.; Goudevenos, J. A.; Chapman, M. J.; Elisaf, M. S.; Tselepis, A. D.24-Nov-2015-
The beneficial effect of tamoxifen on serum lipoprotein-A levels: an additional anti-atherogenic propertyElisaf, M. S.; Bairaktari, E.; Nicolaides, C.; Fountzilas, G.; Tzallas, C.; Siamopoulos, K.; Tsolas, O.; Pavlidis, N.24-Nov-2015-
Body size at birth, blood pressure and metabolic profile in Greek children aged 3 to 10 yearsEvagelidou, E.; Bairaktari, E.; Kiortsis, D.; Tzallas, D.; Tsatsoulis, A.; Andronikou, S.24-Nov-2015-
BRAF mutations, microsatellite instability status and cyclin D1 expression predict metastatic colorectal patients' outcomeSaridaki, Z.; Papadatos-Pastos, D.; Tzardi, M.; Mavroudis, D.; Bairaktari, E.; Arvanity, H.; Stathopoulos, E.; Georgoulias, V.; Souglakos, J.24-Nov-2015-
Changes in serum lipids, lipoproteins and apolipoproteins in patients with acute infectionLiberopoulos, E.; Pappas, G.; Alexandridis, G.; Tsiara, S.; Milionis, H.; Bairaktari, E.; Tsianos, E.; Elisaf, M. S.24-Nov-2015-
Characterization of low density lipoprotein receptor (LDLR) gene mutations in AlbaniaDiakou, M.; Miltiadous, G.; Xenophontos, S.; Cariolou, M.; Heta, N.; Korita, I.; Bulo, A.; Refatllari, E.; Bairaktari, E.; Elisaf, M. S.24-Nov-2015-
Clinical and laboratory characteristics of hypernatraemia in an internal medicine clinicLiamis, G.; Tsimihodimos, V.; Doumas, M.; Spyrou, A.; Bairaktari, E.; Elisaf, M. S.24-Nov-2015-
Clinical significance of creatine kinase isoenzymes for fetal asphyxia in women at laborAndronikou, S.; Bairaktari, E.; Vasiliadou, A. D.; Stefos, T.; Lolis, D.; Tsolas, O.; Lapatsanis, P. D.24-Nov-2015-
The combination of nebivolol plus pravastatin is associated with a more beneficial metabolic profile compared to that of atenolol plus pravastatin in hypertensive patients with dyslipidemia: a pilot studyRizos, E.; Bairaktari, E.; Kostoula, A.; Hasiotis, G.; Achimastos, A.; Ganotakis, E.; Elisaf, M. S.; Mikhailidis, D. P.24-Nov-2015-
Combined treatment with fibrates and small doses of atorvastatin in patients with mixed hyperlipidemiaLiamis, G.; Kakafika, A.; Bairaktari, E.; Miltiadous, G.; Tsimihodimos, V.; Goudevenos, J.; Achimastos, A.; Elisaf, M. S.24-Nov-2015-
Comparison of the efficacy of atorvastatin and micronised fenofibrate in the treatment of mixed hyperlipidemiaMiltiadous, G.; Bairaktari, E.; Tzallas, C.; Tsimihodimos, V.; Liberopoulos, E.; Millionis, H.; Rizos, E.; Elisaf, M. S.24-Nov-2015-
Compositional lipoprotein changes and low-density lipoprotein susceptibility to oxidation in chronic renal failure patients with heavy proteinuriaKarabina, S. A.; Pappas, H.; Miltiadous, G.; Bairaktari, E.; Christides, D.; Tselepis, A.; Elisaf, M.; Siamopoulos, K.24-Nov-2015-
Showing results 7 to 26 of 127 < previous   next >